Clinical Trial Update: A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL) [Phase 1]

View source ↗

Summary

This document reports an ongoing Phase 1 study evaluating CLN-978 in adults with relapsed or refractory B-cell non-Hodgkin lymphoma, currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CLN-978

Snippet

Sponsor: Cullinan Therapeutics Inc. | Conditions: NHL, NHL, Relapsed, Adult | Phase 1 | Status: ACTIVE_NOT_RECRUITING